Ram Waisbourd - 01 Feb 2022 Form 4 Insider Report for 89bio, Inc. (ETNB)

Role
Chief Operating Officer and Chief Business Officer
Signature
/s/ Ryan A. Murr, as attorney-in-fact for Ram Waisbourd
Issuer symbol
ETNB
Transactions as of
01 Feb 2022
Net transactions value
-$26,390
Form type
4
Filing time
03 Feb 2022, 15:30:41 UTC
Previous filing
20 Dec 2021
Next filing
22 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ETNB Common Stock Options Exercise $7,720 +4,000 $1.93* 4,000 01 Feb 2022 Direct
transaction ETNB Common Stock Options Exercise $5,790 +3,000 +75% $1.93* 7,000 01 Feb 2022 Direct
transaction ETNB Common Stock Sale $39,900 -7,000 -100% $5.70 0 01 Feb 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ETNB Stock Option (Right to Buy) Options Exercise $0 -4,000 -22% $0.000000 14,203 01 Feb 2022 Common Stock 4,000 $1.93 Direct F2
transaction ETNB Stock Option (Right to Buy) Options Exercise $0 -3,000 -49% $0.000000 3,106 01 Feb 2022 Common Stock 3,000 $1.93 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed pursuant to a Rule 10b5-1 trading plan in multiple trades at prices ranging from $5.43 to $5.97. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 This option represents a right to purchase a total of 102,203 shares of the Issuer's common stock, one quarter of which vested on May 1, 2019, with the remaining three quarters vesting in equal quarterly installments over the following three years.
F3 This option represents a right to purchase a total of 20,106 shares of the Issuer's common stock, one quarter of which vested on May 1, 2019, with the remaining three quarters vesting in equal quarterly installments over the following three years.

Remarks:

Chief Operating Officer and Chief Business Officer